Viral Genetics changes name and announces reverse stock split

In California, Viral Genetics will be changing its name to VG Life Sciences, and implement a 1-for-600 reverse split of its common stock. The name change and the reverse stock split are expected to be become effective on or about November 26, 2012, pending review and acceptance by FINRA. Haig Keledjian, Viral Genetics’ CEO, stated, “VG Life Sciences, Inc. more accurately depicts our intellectual property and the business focus which is broader than pharmaceuticals and now reaches into biofuels, agricultural technology and other high-growth industries.”